Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 199

1.

Intussusception among infants given an oral rotavirus vaccine.

Murphy TV, Gargiullo PM, Massoudi MS, Nelson DB, Jumaan AO, Okoro CA, Zanardi LR, Setia S, Fair E, LeBaron CW, Wharton M, Livengood JR; Rotavirus Intussusception Investigation Team.

N Engl J Med. 2001 Feb 22;344(8):564-72. Erratum in: N Engl J Med 2001 May 17;344(20):1564. Livingood, JR [corrected to Livengood, JR].

2.

An analysis of rotavirus vaccine reports to the vaccine adverse event reporting system: more than intussusception alone?

Haber P, Chen RT, Zanardi LR, Mootrey GT, English R, Braun MM; VAERS Working Group.

Pediatrics. 2004 Apr;113(4):e353-9.

PMID:
15060267
3.

Population-based study of rotavirus vaccination and intussusception.

Kramarz P, France EK, Destefano F, Black SB, Shinefield H, Ward JI, Chang EJ, Chen RT, Shatin D, Hill J, Lieu T, Ogren JM.

Pediatr Infect Dis J. 2001 Apr;20(4):410-6.

PMID:
11332666
4.

Neonatal administration of rhesus rotavirus tetravalent vaccine.

Vesikari T, Karvonen A, Forrest BD, Hoshino Y, Chanock RM, Kapikian AZ.

Pediatr Infect Dis J. 2006 Feb;25(2):118-22.

PMID:
16462287
5.

Rotavirus vaccines and vaccination in Latin America.

Linhares AC, Bresee JS.

Rev Panam Salud Publica. 2000 Nov;8(5):305-31. Review.

PMID:
11190969
6.

Safety, efficacy, and immunogenicity of 2 doses of bovine-human (UK) and rhesus-rhesus-human rotavirus reassortant tetravalent vaccines in Finnish children.

Vesikari T, Karvonen AV, Majuri J, Zeng SQ, Pang XL, Kohberger R, Forrest BD, Hoshino Y, Chanock RM, Kapikian AZ.

J Infect Dis. 2006 Aug 1;194(3):370-6. Epub 2006 Jun 23.

PMID:
16826486
7.

Suspension of rotavirus vaccine after reports of intussusception--United States, 1999.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2004 Sep 3;53(34):786-9. Erratum in: MMWR Morb Mortal Wkly Rep. 2004 Sep 24;53(37):879.

8.

Intussusception among recipients of rotavirus vaccine--United States, 1998-1999.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 1999 Jul 16;48(27):577-81.

9.

Intussusception risk and health benefits of rotavirus vaccination in Mexico and Brazil.

Patel MM, López-Collada VR, Bulhões MM, De Oliveira LH, Bautista Márquez A, Flannery B, Esparza-Aguilar M, Montenegro Renoiner EI, Luna-Cruz ME, Sato HK, Hernández-Hernández Ldel C, Toledo-Cortina G, Cerón-Rodríguez M, Osnaya-Romero N, Martínez-Alcazar M, Aguinaga-Villasenor RG, Plascencia-Hernández A, Fojaco-González F, Hernández-Peredo Rezk G, Gutierrez-Ramírez SF, Dorame-Castillo R, Tinajero-Pizano R, Mercado-Villegas B, Barbosa MR, Maluf EM, Ferreira LB, de Carvalho FM, dos Santos AR, Cesar ED, de Oliveira ME, Silva CL, de Los Angeles Cortes M, Ruiz Matus C, Tate J, Gargiullo P, Parashar UD.

N Engl J Med. 2011 Jun 16;364(24):2283-92. doi: 10.1056/NEJMoa1012952.

10.

Symptoms associated with rhesus-human reassortant rotavirus vaccine in infants.

Joensuu J, Koskenniemi E, Vesikari T.

Pediatr Infect Dis J. 1998 Apr;17(4):334-40.

PMID:
9576390
11.

Age dependence of the risk of intussusception following [corrected] rhesus-human reassortant rotavirus tetravalent vaccine: is it beyond doubt?

Chen J, Heyse JF, Heaton P, Kuter BJ.

Am J Epidemiol. 2010 May 1;171(9):1046-54. doi: 10.1093/aje/kwq048. Epub 2010 Apr 16. Erratum in: Am J Epidemiol. 2010 Jul 1;172(1):125.

PMID:
20400464
12.

Simultaneous administration of oral rhesus-human reassortant tetravalent (RRV-TV) rotavirus vaccine and oral poliovirus vaccine (OPV) in Thai infants.

Migasena S, Simasathien S, Samakoses R, Pitisuttitham P, Sangaroon P, van Steenis G, Beuvery EC, Bugg H, Bishop R, Davidson BL, et al.

Vaccine. 1995 Feb;13(2):168-74.

PMID:
7625111
13.

More on RotaShield and intussusception: the role of age at the time of vaccination.

Simonsen L, Viboud C, Elixhauser A, Taylor RJ, Kapikian AZ.

J Infect Dis. 2005 Sep 1;192 Suppl 1:S36-43.

PMID:
16088803
14.

The first oral rotavirus vaccine, 1998-1999: estimates of uptake from the National Immunization Survey.

Smith PJ, Schwartz B, Mokdad A, Bloch AB, McCauley M, Murphy TV.

Public Health Rep. 2003 Mar-Apr;118(2):134-43.

15.

Rotavirus live, oral, pentavalent vaccine.

Tom-Revzon C.

Clin Ther. 2007 Dec;29(12):2724-37. doi: 10.1016/j.clinthera.2007.12.018. Review.

PMID:
18201590
16.

Rotavirus vaccines and intussusception risk.

Bines JE.

Curr Opin Gastroenterol. 2005 Jan;21(1):20-5. Review.

PMID:
15687880
17.
18.

Intussusception, infection, and immunization: summary of a workshop on rotavirus.

Kombo LA, Gerber MA, Pickering LK, Atreya CD, Breiman RF.

Pediatrics. 2001 Aug;108(2):E37.

PMID:
11483847
19.

Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine.

Vesikari T, Matson DO, Dennehy P, Van Damme P, Santosham M, Rodriguez Z, Dallas MJ, Heyse JF, Goveia MG, Black SB, Shinefield HR, Christie CD, Ylitalo S, Itzler RF, Coia ML, Onorato MT, Adeyi BA, Marshall GS, Gothefors L, Campens D, Karvonen A, Watt JP, O'Brien KL, DiNubile MJ, Clark HF, Boslego JW, Offit PA, Heaton PM; Rotavirus Efficacy and Safety Trial (REST) Study Team.

N Engl J Med. 2006 Jan 5;354(1):23-33.

20.

Intussusception among young children in Europe.

Huppertz HI, Soriano-Gabarró M, Grimprel E, Franco E, Mezner Z, Desselberger U, Smit Y, Wolleswinkel-van den Bosch J, De Vos B, Giaquinto C.

Pediatr Infect Dis J. 2006 Jan;25(1 Suppl):S22-9. Review.

PMID:
16397426

Supplemental Content

Support Center